Clinical Trial Update: Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating Sho-saiko-to for reducing hepatitis C viral load was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sho-Saiko-To

Snippet

Sponsor: University of Virginia | Conditions: Hepatitis C Virus | Phase 1 | Status: WITHDRAWN